Geneva, May 4 -- International Clinical Trials Registry received information related to the study (DRKS00039996) titled 'Tricuspid regurgitation and additional cardiac amyloidosis: early diagnosis and treatment to prevent disease progression' on April 22.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: diagnostic
Primary Sponsor: Deutsches Herzzentrum der Charite
Condition:
I36.1
E85
Nonrheumatic tricuspid (valve) insufficiency
Amyloidosis
Intervention:
Group 1: Patients with and without cardiac amyloidosis (CA) and tricuspid regurgitation (TR)
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/05/2026
Target Sample Size: 600
Countries of Recruitment:
Ger...